• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Amneal Pharmaceuticals (AMRX)

Common Shares
Sell: $12.50|Buy: $13.00|Change: 0.64 (-4.79%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Address

400 Crossing Boulevard
3rd Floor
Bridgewater
NJ
USA
08807

Telephone

+1 908 9473120

Website

https://www.amneal.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Amneal Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20262027-02-26T08:30:00
Amneal Pharmaceuticals Inc Fourth Quarter Earnings Results for 20262027-02-26T00:00:00
Amneal Pharmaceuticals Inc Annual Report for 20262027-02-26T00:00:00
Amneal Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20262026-10-30T08:30:00
Amneal Pharmaceuticals Inc Third Quarter Earnings Results for 20262026-10-30T00:00:00
Amneal Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20262026-08-05T08:30:00
Amneal Pharmaceuticals Inc Second Quarter Earnings Results for 20262026-08-05T00:00:00
Amneal Pharmaceuticals Inc Annual General Meeting for 20262026-05-06T09:00:00
Amneal Pharmaceuticals Inc First Quarter Earnings Conference Call for 20262026-05-01T08:30:00
Amneal Pharmaceuticals Inc First Quarter Earnings Results for 20262026-05-01T00:00:00
Barclays 28(th) Annual Global Healthcare Conference2026-03-10T11:00:00

Previous key dates

NameKey Date
Barclays 28(th) Annual Global Healthcare Conference2026-03-10T11:00:00
Amneal Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252026-02-27T08:30:00
Amneal Pharmaceuticals Inc Fourth Quarter Earnings Result for 20252026-02-27T00:00:00
Amneal Pharmaceuticals Inc Annual Report for 20252026-02-27T00:00:00
Amneal Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-10-30T08:30:00
Amneal Pharmaceuticals Inc Third Quarter Earnings Result for 20252025-10-30T00:00:00
Amneal Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20252025-08-05T08:30:00
Amneal Pharmaceuticals Inc Second Quarter Earnings Result for 20252025-08-05T00:00:00
Amneal Pharmaceuticals Inc Annual General Meeting for 20252025-05-06T09:00:00
Amneal Pharmaceuticals Inc First Quarter Earnings Conference Call for 20252025-05-02T08:30:00
Amneal Pharmaceuticals Inc First Quarter Earnings Results for 20252025-05-02T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.